Logo 1 Logo 2

Clinical Trial Details

Trial ID: L0744
Source ID: NCT01356966
Associated Drug: Tetrahydrobiopterin
Title: Exercise Intolerance in Renal Failure
Acronym: EIRF
Status: COMPLETED
Study Results: YES
Results: https://ClinicalTrials.gov/show/NCT01356966/results
Conditions: Kidney Failure, Chronic
Interventions: DRUG: Tetrahydrobiopterin|DRUG: Placebo|DIETARY_SUPPLEMENT: Folate
Outcome Measures: Primary: Change in Resting Muscle Sympathetic Nerve Activity (MSNA), Baseline, 12 weeks | Secondary: Change in Mean Central Augmentation Index (AIx), The augmentation index (AIx) is a measure of systemic arterial stiffness, and is defined as the ratio of augmentation (Δ P) to central pulse pressure and expressed as percent. AIx = (ΔP/PP) x 100, where P = pressure and PP = Pulse Pressure. The mean AIx for each group was estimated as an average and expressed as a change from baseline to 12 weeks., Baseline, 12 weeks|Change in Heart-rate-corrected Augmentation Index (AIx), The augmentation index (AIx) is a measure of systemic arterial stiffness, and is defined as the ratio of augmented aortic pressure (Δ P) to central pulse pressure expressed as a percent. AIx = (ΔP/PP) x 100, where P = pressure and PP = Pulse Pressure. Because heart rate (HR) affects AIx, AIx was corrected to a HR of 75 beats per minute (bpm) as follows: HR-corrected AIx = -0.39 x (75 - HR) + AIx. The mean AIx for each group was estimated as an average and expressed as a change from baseline to 12 weeks., Baseline, 12 weeks
Sponsor/Collaborators: Sponsor: Emory University | Collaborators: National Institutes of Health (NIH)|National Heart, Lung, and Blood Institute (NHLBI)
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE2
Enrollment: 74
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Start Date: 2011-05
Completion Date: 2014-05
Results First Posted: 2015-06-01
Last Update Posted: 2015-06-01
Locations: Emory University Hospital, Atlanta, Georgia, 30322, United States|Atlanta VA Medical Center, Decatur, Georgia, 30033, United States
URL: https://clinicaltrials.gov/show/NCT01356966